Table of Content

Table of Contents

1. Executive Summary

2. Global Neurological Biomarker Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Neurological Biomarker Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Neurological Biomarker Market by Type
3.3.1: Genomic
3.3.2: Proteomic
3.3.3: Metabolomic
3.3.4: Imaging
3.3.5: Others
3.4: Global Neurological Biomarker Market by Application
3.4.1: Alzheimer’s Disease
3.4.2: Parkinson’s Disease
3.4.3: Multiple Sclerosis
3.4.4: Autism Spectrum Disorder
3.4.5: Others
3.5: Global Neurological Biomarker Market by End Use
3.5.1: Hospital & Hospital Laboratories
3.5.2: Independent Clinical Diagnostic Centers
3.5.3: Research Organizations and Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Neurological Biomarker Market by Region
4.2: North American Neurological Biomarker Market
4.2.1: North American Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.2.2: North American Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.3: European Neurological Biomarker Market
4.3.1: European Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.3.2: European Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.4: APAC Neurological Biomarker Market
4.4.1: APAC Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.4.2: APAC Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
4.5: ROW Neurological Biomarker Market
4.5.1: ROW Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
4.5.2: ROW Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neurological Biomarker Market by Type
6.1.2: Growth Opportunities for the Global Neurological Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Neurological Biomarker Market by End Use
6.1.4: Growth Opportunities for the Global Neurological Biomarker Market by Region
6.2: Emerging Trends in the Global Neurological Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neurological Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurological Biomarker Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Abbott
7.2: Thermo Fisher Scientific
7.3: Bio-Rad Laboratories
7.4: Merck
7.5: Johnson & Johnson Services
7.6: BANYAN BIOMARKERS
7.7: Myriad Genetics